Sio Capital Management, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001482416

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q2 2026 · 59 positions · Total reported value $604.29M · Top-10 concentration 48.6% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.2% · 16 new · 22 cut · 33 exited

Active Share (vs S&P 500): 99.1% · vs QQQ: 99.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +18.0% · vs SPY +3.2% · Prev Value $697.31M — last quarter positions weighted by this quarter price moves · ranking

In its Q2 2026 13F filing, Sio Capital Management, LLC disclosed 59 equity positions with a combined reported value of $604.29M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 48.6% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q2 2026 were AVR ($54.63M), COR ($49.12M), MMS ($38.45M). By sector, the heaviest allocations are Health Care 86.6%, Consumer Discretionary 6.4%. Versus the prior quarter, allocation shifted toward Health Care (+3.6pp) and away from Consumer Discretionary (-0.7pp), Technology (-2.5pp).

Versus the prior quarter, Sio Capital Management, LLC opened 16 new positions, trimmed 22 and fully exited 33, a turnover rate of 77.2% of positions. The portfolio's overlap with the prior quarter was 47% of names.

The largest new positions opened in Q2 2026 were ALLO ($27.71M), GMED ($23.85M), SLS ($18.17M).

Of the 33 positions fully exited versus the prior quarter, the largest were CORT ($27.20M), LIVN ($26.80M), EMBC ($16.33M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q2 2026)

  • ALLO ALLOGENE THERAPEUTICS INC · $27.71M
  • GMED GLOBUS MED INC CL A · $23.85M
  • SLS SELLAS LIFE SCIENCES GROUP I · $18.17M
  • IDYA IDEAYA BIOSCIENCES INC · $17.90M
  • CI CIGNA GROUP · $15.92M
  • VTRS VIATRIS INC COM · $15.15M
  • REGN REGENERON PHARMACEUTICALS COM · $11.22M
  • BMY BRISTOL MYERS · $11.15M

Fully Exited (vs previous quarter)

  • CORT CORCEPT THERAPEUTICS INC · prev qtr: $27.20M
  • LIVN LIVANOVA PLC · prev qtr: $26.80M
  • EMBC EMBECTA CORP · prev qtr: $16.33M
  • ABVX ABIVAX SA · prev qtr: $15.12M
  • HAE HAEMONETICS CORP/MASS · prev qtr: $12.44M
  • TFX TELEFLEX INC · prev qtr: $11.34M
  • BMRN BIOMARIN PHARMACEUTICAL INC · prev qtr: $10.97M
  • GPCR STRUCTURE THERAPEUTICS INC · prev qtr: $10.08M

Insider Transactions (Form 4)

Latest Sio Capital Management, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Sio Capital Management, LLC, based in New York, NY, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 59 positions worth $604.29M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-78021 (status: Approved), registered 2013-05-16
  • Regulatory AUM (Form ADV): $1.29B as of 2026-03-18
  • Client mix (by RAUM): pension and profit-sharing plans 53%, pooled investment vehicles 47%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: siocapital.com

Portfolio Structure

  • 59 positions · $604.29M reported value (Q2 2026)
  • Top 10 holdings = 48.6% of reported value
  • Largest position: AVR (ANTERIS TECHNOLOGIES GLOBAL COM) at 9.0%
  • Average position size: $10.24M

Sector Tilt

  • Health Care 86.6%
  • Consumer Discretionary 6.4%
  • Information Technology 3.1%
  • (classified holdings cover 98% of value)

Quarterly Activity

  • Q2 2026: 16 new, 10 added, 22 reduced, 33 exited
  • 11 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 86.6%
Technology 3.1%
Other 2.4%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 5.55M $54.63M 9.04%
9.04%
Add
2 173.59K $49.12M 8.13%
8.13%
Add
3 715.27K $38.45M 6.36%
6.36%
Reduce
4 13.32M $27.71M 4.59%
4.59%
New
5 301.82K $23.85M 3.95%
3.95%
New
6 436.70K $22.89M 3.79%
3.79%
Add
7 695.32K $22.21M 3.67%
3.67%
Add
8 925.83K $19.01M 3.15%
3.15%
Reduce
9 1.23M $18.17M 3.01%
3.01%
New
10 480.38K $17.90M 2.96%
2.96%
New
11 177.12K $16.86M 2.79%
2.79%
Add
12 57.75K $15.92M 2.63%
2.63%
New
13 364.20K $15.54M 2.57%
2.57%
Add
14 88.19K $15.32M 2.54%
2.54%
Reduce
15 954.30K $15.15M 2.51%
2.51%
New
16 1.10M $14.51M 2.40%
2.40%
Hold
17 307.66K $12.82M 2.12%
2.12%
Reduce
18 128.66K $11.67M 1.93%
1.93%
Reduce
19 110.02K $11.51M 1.91%
1.91%
Reduce
20 131.44K $11.32M 1.87%
1.87%
Add
21 18.00K $11.22M 1.86%
1.86%
New
22 193.50K $11.15M 1.84%
1.84%
New
23 142.50K $11.15M 1.84%
1.84%
New
24 1.08M $10.96M 1.81%
1.81%
Reduce
25 1.59M $9.05M 1.50%
1.50%
Add
26 623.13K $8.91M 1.48%
1.48%
Reduce
27 1.30M $8.59M 1.42%
1.42%
New
28 97.31K $8.05M 1.33%
1.33%
Reduce
29 1.92M $7.34M 1.22%
1.22%
Reduce
30 1.00M $6.94M 1.15%
1.15%
Add
31 208.50K $6.52M 1.08%
1.08%
New
32 1.49M $6.18M 1.02%
1.02%
Reduce
33 59.25K $5.78M 0.96%
0.96%
Reduce
34 127.81K $5.62M 0.93%
0.93%
Reduce
35 539.49K $5.30M 0.88%
0.88%
Reduce
36 208.56K $5.29M 0.88%
0.88%
Reduce
37 73.95K $5.19M 0.86%
0.86%
Reduce
38 1.08M $4.92M 0.81%
0.81%
Hold
39 617.67K $3.80M 0.63%
0.63%
Add
40 2.63M $3.53M 0.58%
0.58%
Reduce
41 369.04K $3.16M 0.52%
0.52%
New
42 1.01M $2.70M 0.45%
0.45%
Reduce
43 124.17K $2.63M 0.43%
0.43%
Reduce
44 75.00K $2.60M 0.43%
0.43%
New
45 529.93K $2.56M 0.42%
0.42%
Reduce
46 1.00M $1.94M 0.32%
0.32%
Hold
47 327.24K $1.89M 0.31%
0.31%
Hold
48 904.27K $1.58M 0.26%
0.26%
Hold
49 152.46K $1.46M 0.24%
0.24%
Hold
50 48.48K $1.09M 0.18%
0.18%
New

Holdings Prediction Model

Predicts next-quarter Top-10 holdings and weights from the fund's own historical trading轨迹 (add / reduce / hold) plus each stock's price momentum and relative volume. Strictly no look-ahead: a prediction for quarter T+1 uses only data through quarter T. Weights are shares of the modelled portfolio.

The next-quarter predicted Top 10 (2026-Q3) is shown in the «Latest Q · Forecast» tab above, in the same holdings format. That view is for logged-in accounts: 3 views per day on Free, unlimited on Gold/Diamond.

Latest-Quarter Accuracy (2026-Q2)

P 50% R 50% F1 50% (modelled on 2026-Q1; 5/10 hit)

Low-confidence forecast This fund replaces about 54% of its Top-10 each quarter and backtests at F1 46% (threshold 80%). Holdings in high-turnover portfolios cannot be forecast from their own history; the figures below are illustrative.

Historical Backtest (10 quarters)

Avg precision 46% · recall 46% · F1 46% · avg rank error 4.0 · Top-10 turnover 54%

Quarter Prec. Recall F1 Predicted Top 10 Actual Top 10
2024-Q1 50% 50% 50% MRTX · GRCL · CI · LH · GMED · INSM · GSK · IMGN · UTHR · EMBC LH · INSM · CI · GMED · MDGL · GSK · ZBH · MDT · OGN · TYRA
2024-Q2 50% 50% 50% LH · INSM · CI · GMED · MDGL · GSK · ZBH · MDT · TYRA · OGN INSM · LH · TFX · ZBH · SNN · PCRX · OGN · GSK · CRBP · VXRT
2024-Q3 40% 40% 40% INSM · LH · TFX · ZBH · PCRX · SNN · OGN · GSK · CRBP · TYRA LH · ISRG · TEVA · MMS · ZBH · VXRT · KVUE · TFX · TYRA · IRON
2024-Q4 40% 40% 40% LH · ISRG · TEVA · ZBH · MMS · VXRT · TFX · KVUE · TYRA · IRON ICLR · MMS · CI · LH · SNY · ZBH · DRUG · AVR · ANNX · TFX
2025-Q1 60% 60% 60% ICLR · MMS · CI · LH · ZBH · SNY · DRUG · ANNX · AVR · TFX ICLR · MMS · MRK · ZBH · NBIX · LH · DRUG · GMED · TFX · EMBC
2025-Q2 50% 50% 50% MMS · ICLR · MRK · ZBH · NBIX · DRUG · LH · TFX · EMBC · GMED MMS · IRON · GMED · CNC · MRK · DRUG · NBIX · BMRN · ANNX · IDXX
2025-Q3 40% 40% 40% MMS · IRON · CNC · GMED · BMRN · DRUG · MRK · NBIX · ANNX · IDXX MMS · CELC · SNY · DNTH · ALKS · IRON · MRK · HSIC · CNC · KVUE
2025-Q4 40% 40% 40% MMS · CELC · SNY · DNTH · IRON · ALKS · CNC · KVUE · HSIC · MRK CELC · CI · SNY · MMS · ZBH · RYTM · KVUE · OGN · ICLR · WAY
2026-Q1 40% 40% 40% CI · SNY · CELC · MMS · ZBH · KVUE · RYTM · OGN · ICLR · DNTH MMS · WAY · ICLR · COR · DNTH · AVR · CORT · LIVN · TYRA · CELC
2026-Q2 ★ 50% 50% 50% MMS · WAY · ICLR · COR · AVR · DNTH · LIVN · CORT · TYRA · ANIP AVR · COR · MMS · ALLO · GMED · GSK · TYRA · WAY · SLS · IDYA

★ = latest filed quarter (predicted vs actual). Recall = share of the real Top 10 caught by the model; precision = share of the predicted Top 10 that were real.

FAQ

What did Sio Capital Management, LLC buy in 2026-Q2?

In its 2026-Q2 13F filing, Sio Capital Management, LLC reported 59 equity positions worth $604.29M in aggregate; its largest disclosed positions were AVR ($54.63M), COR ($49.12M), MMS ($38.45M).

How large is Sio Capital Management, LLC's portfolio?

Sio Capital Management, LLC reported $604.29M of long equity holdings across 59 positions as of 2026-Q2. Top-10 holdings account for 48.6% of reported value.

What is Sio Capital Management, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sio-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →